Felix Zijlstra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Felix Zijlstra has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Eng-Shiong Tan
3 shared publications- Iwan Cc van der Horst
Department of Critical Care, University Medical Center Groningen, The Netherlands
3 shared publications - Pieter J. Vlaar
Department of Internal Medicine1 Department of Clinical Pharmacy and Toxicology2 Martini Hospital Unit of PharmacoEpidemiology and PharmacoEconomics3 Department of Pharmacy University of Groningen Department of Clinical Microbiology4 Martini Hospital Groningen, Netherlands
3 shared publications - Albert J. H. Suurmeijer
Department of Pathology University Medical Center Groningen, University of Groningen Groningen The Netherlands
2 shared publications Bart J.G.L. de Smet
2 shared publications- Geke A. P. Hospers
Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands
2 shared publications
Latest Publications
- 11 June 2015
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 5 (4) , 328-338
Long-term outcome of patients after out-of-hospital cardiac arrest in relation to treatment: a single-centre study
Outcome after out-of-hospital cardiac arrest (OHCA) remains poor. With the introduction of automated external defibrillators, percutaneous coronary intervention (PCI) and mild therapeutic hypothermia (MTH) the prognosis of patients after OHCA appears to be improving. The aim of this study was to evaluate short and long-term outcome among a non-selected population of patients who experienced OHCA and were admitted to a hospital working within a ST elevation myocardial infarction network. All patients who achieved return of spontaneous circulation (ROSC) (n=456) admitted to one hospital after OHCA were included. Initial rhythm, reperfusion therapy with PCI, implementation of MTH and additional medical management were recorded. The primary outcome measure was survival (hospital and long term). Neurological status was measured as cerebral performance category. The inclusion period was January 2003 to August 2010. Follow-up was complete until April 2014. The mean patient age was 63±14 years and 327 (72%) were men. The initial rhythm was ventricular fibrillation, pulseless electrical activity, asystole and pulseless ventricular tachycardia in 322 (71%), 58 (13%), 55 (12%) and 21 (5%) of the 456 patients, respectively. Treatment included PCI in 191 (42%) and MTH in 188 (41%). Overall in-hospital and long-term (5-year) survival was 53% (n=240) and 44% (n=202), respectively. In the 170 patients treated with primary PCI, in-hospital survival was 112/170 (66%). After hospital discharge these patients had a 5-year survival rate of 99% and cerebral performance category was good in 92%. In this integrated ST elevation myocardial infarction network survival and neurological outcome of selected patients with ROSC after OHCA and treated with PCI was good. There is insufficient evidence about the outcome of this approach, which has a significant impact on utilisation of resources. Good quality randomised controlled trials are needed. In selected patients successfully resuscitated after OHCA of presumed cardiac aetiology, we believe that a more liberal application of primary PCI may be considered in experienced acute cardiac referral centres.
- 11 June 2015
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 5 (4) , 328-338
Long-term outcome of patients after out-of-hospital cardiac arrest in relation to treatment: a single-centre study
Outcome after out-of-hospital cardiac arrest (OHCA) remains poor. With the introduction of automated external defibrillators, percutaneous coronary intervention (PCI) and mild therapeutic hypothermia (MTH) the prognosis of patients after OHCA appears to be improving. The aim of this study was to evaluate short and long-term outcome among a non-selected population of patients who experienced OHCA and were admitted to a hospital working within a ST elevation myocardial infarction network. All patients who achieved return of spontaneous circulation (ROSC) (n=456) admitted to one hospital after OHCA were included. Initial rhythm, reperfusion therapy with PCI, implementation of MTH and additional medical management were recorded. The primary outcome measure was survival (hospital and long term). Neurological status was measured as cerebral performance category. The inclusion period was January 2003 to August 2010. Follow-up was complete until April 2014. The mean patient age was 63±14 years and 327 (72%) were men. The initial rhythm was ventricular fibrillation, pulseless electrical activity, asystole and pulseless ventricular tachycardia in 322 (71%), 58 (13%), 55 (12%) and 21 (5%) of the 456 patients, respectively. Treatment included PCI in 191 (42%) and MTH in 188 (41%). Overall in-hospital and long-term (5-year) survival was 53% (n=240) and 44% (n=202), respectively. In the 170 patients treated with primary PCI, in-hospital survival was 112/170 (66%). After hospital discharge these patients had a 5-year survival rate of 99% and cerebral performance category was good in 92%. In this integrated ST elevation myocardial infarction network survival and neurological outcome of selected patients with ROSC after OHCA and treated with PCI was good. There is insufficient evidence about the outcome of this approach, which has a significant impact on utilisation of resources. Good quality randomised controlled trials are needed. In selected patients successfully resuscitated after OHCA of presumed cardiac aetiology, we believe that a more liberal application of primary PCI may be considered in experienced acute cardiac referral centres.
- 1 October 2013
- Published by Elsevier in International Journal of Cardiology
- Vol. 168 (5) , 4981-4982
The feasibility of optical coherence tomography guided thrombus aspiration in patients with non-ST-elevation myocardial infarction after initial conservative therapy – A pilot study
- 1 October 2013
- Published by Elsevier in International Journal of Cardiology
- Vol. 168 (5) , 4981-4982
The feasibility of optical coherence tomography guided thrombus aspiration in patients with non-ST-elevation myocardial infarction after initial conservative therapy – A pilot study
- 1 January 2011
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 6 (6) , 760-767
Operator dependence of outcome after primary percutaneous coronary intervention
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 January 2011
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 6 (6) , 760-767
Operator dependence of outcome after primary percutaneous coronary intervention
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 January 2010
- Vol. 154, A1971
[Secondary prevention following myocardial infarction may be improved. Long-term medication use according to practice guidelines].
To determine the percentage of myocardial infarction patients in the Netherlands still using medication for secondary prevention according to current practice guidelines at the long term. Follow-up study of a prospective randomised clinical trial. From 1071 myocardial infarction patients participating in a trial we obtained data on long-term medication use during follow-up. The medication was compared with the recommendations of the European Society of Cardiology for the use of statins, antithrombotics, renin-angiotensin-aldosterone system inhibitors and beta-blockers. From 922 patients (86%) data were available on the medication use at on average 36 months (SD: 7) after myocardial infarction. At that time, 51% of the patients used medication conformable to the guideline. The use of ACE-inhibitors or angiotensin II-receptor blockers was lowest (71% of all patients). At discharge from the hospital the patient group using medication according to the guideline during long-term follow-up had significantly more often received medication conformable to the guideline. Approximately half of the patients with myocardial infarction still adhere to use of medication for secondary prevention according to current guidelines at the long term. In particular, adherence of the cardiologist prescribing medication at discharge deserves more attention.
- 1 January 2010
- Vol. 154, A1971
[Secondary prevention following myocardial infarction may be improved. Long-term medication use according to practice guidelines].
To determine the percentage of myocardial infarction patients in the Netherlands still using medication for secondary prevention according to current practice guidelines at the long term. Follow-up study of a prospective randomised clinical trial. From 1071 myocardial infarction patients participating in a trial we obtained data on long-term medication use during follow-up. The medication was compared with the recommendations of the European Society of Cardiology for the use of statins, antithrombotics, renin-angiotensin-aldosterone system inhibitors and beta-blockers. From 922 patients (86%) data were available on the medication use at on average 36 months (SD: 7) after myocardial infarction. At that time, 51% of the patients used medication conformable to the guideline. The use of ACE-inhibitors or angiotensin II-receptor blockers was lowest (71% of all patients). At discharge from the hospital the patient group using medication according to the guideline during long-term follow-up had significantly more often received medication conformable to the guideline. Approximately half of the patients with myocardial infarction still adhere to use of medication for secondary prevention according to current guidelines at the long term. In particular, adherence of the cardiologist prescribing medication at discharge deserves more attention.
- 1 December 2009
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 2 (6) , e6
Response to Letter Regarding Article “Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial”
- 1 December 2009
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 2 (6) , e6
Response to Letter Regarding Article “Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial”
- 28 July 2009
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (4)
Response to Letter Regarding Article, “Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
- 28 July 2009
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (4)
Response to Letter Regarding Article, “Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
- 1 July 2009
- Published by Elsevier in Journal of Electrocardiology
- Vol. 42 (4) , 310-318
Predictive value of Q waves on the 12-lead electrocardiogram after reperfusion therapy for ST elevation myocardial infarction
- 1 July 2009
- Published by Elsevier in Journal of Electrocardiology
- Vol. 42 (4) , 310-318
Predictive value of Q waves on the 12-lead electrocardiogram after reperfusion therapy for ST elevation myocardial infarction
- 1 January 2009
- Vol. 153, B98
[Experiences of combined heart-lung transplantations in the University Medical Center Groningen].
Reporting the results of combined heart-lung transplantation in the University Medical Center Groningen (UMCG), the Netherlands. Retrospective study. Data were retrieved of patients who underwent a combined heart-lung transplantation in the UMCG between December 1996 and December 2007. Demographic, clinical and other relevant characteristics were recorded, as well as post-transplantation morbidity and mortality. The study group consisted of 14 patients (3 men and 11 women) with a mean age of 41 years. Indications for heart-lung transplantation were: congenital heart disease complicated by pulmonary hypertension (6 patients), idiopathic pulmonary hypertension with severe right ventricle failure (4 patients), lung fibrosis with severe right ventricle failure (1 patient), cystic fibrosis with systolic left ventricle failure (1 patient), pulmonary hypertension after thoracic radiation and chemotherapy (1 patient) and re-transplantation after lung-transplant failure (1 patient). The mean waiting time prior to operation was approximately 1.5 years. 9 of the 14 patients (64%) underwent such a marked clinical deterioration during the waiting period that they were given a 'very high urgency status' for transplantation. Almost half of patients became dependent on supplementary intravenous inotropics during the waiting period. At the end of the study 6 of the 14 patients (43%) were alive, with a mean survival period of 58 months (range: 6-132). Infection was the cause of death in 4 of the 8 patients. Of the 8 deceased patients, 4 were underweight preoperatively (BMI < 18.5 kg/m2) and were cachectic. This was the case in only 1 of the 6 surviving patients. A combined heart-lung transplantation is a rare operation in the Netherlands. The waiting time in this study was long and the post-transplantation mortality was high. Underweight (cachexia), a sign of a poor clinical condition, appears to be associated with mortality.
- 1 January 2009
- Vol. 153, B98
[Experiences of combined heart-lung transplantations in the University Medical Center Groningen].
Reporting the results of combined heart-lung transplantation in the University Medical Center Groningen (UMCG), the Netherlands. Retrospective study. Data were retrieved of patients who underwent a combined heart-lung transplantation in the UMCG between December 1996 and December 2007. Demographic, clinical and other relevant characteristics were recorded, as well as post-transplantation morbidity and mortality. The study group consisted of 14 patients (3 men and 11 women) with a mean age of 41 years. Indications for heart-lung transplantation were: congenital heart disease complicated by pulmonary hypertension (6 patients), idiopathic pulmonary hypertension with severe right ventricle failure (4 patients), lung fibrosis with severe right ventricle failure (1 patient), cystic fibrosis with systolic left ventricle failure (1 patient), pulmonary hypertension after thoracic radiation and chemotherapy (1 patient) and re-transplantation after lung-transplant failure (1 patient). The mean waiting time prior to operation was approximately 1.5 years. 9 of the 14 patients (64%) underwent such a marked clinical deterioration during the waiting period that they were given a 'very high urgency status' for transplantation. Almost half of patients became dependent on supplementary intravenous inotropics during the waiting period. At the end of the study 6 of the 14 patients (43%) were alive, with a mean survival period of 58 months (range: 6-132). Infection was the cause of death in 4 of the 8 patients. Of the 8 deceased patients, 4 were underweight preoperatively (BMI < 18.5 kg/m2) and were cachectic. This was the case in only 1 of the 6 surviving patients. A combined heart-lung transplantation is a rare operation in the Netherlands. The waiting time in this study was long and the post-transplantation mortality was high. Underweight (cachexia), a sign of a poor clinical condition, appears to be associated with mortality.
- 1 September 2008
- Published by Elsevier in The Lancet
- Vol. 372 (9643) , 1034-1035
Thrombus aspiration during percutaneous coronary intervention – Authors' reply
- 1 September 2008
- Published by Elsevier in The Lancet
- Vol. 372 (9643) , 1034-1035
Thrombus aspiration during percutaneous coronary intervention – Authors' reply
- Top Cited Papers
- 7 February 2008
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (6) , 557-567
Thrombus Aspiration during Primary Percutaneous Coronary Intervention
Primary percutaneous coronary intervention (PCI) is effective in opening the infarct-related artery in patients with myocardial infarction with ST-segment elevation. However, the embolization of atherothrombotic debris induces microvascular obstruction and diminishes myocardial reperfusion.
- 7 February 2008
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (6) , 557-567
Top Cited PapersThrombus Aspiration during Primary Percutaneous Coronary Intervention
Primary percutaneous coronary intervention (PCI) is effective in opening the infarct-related artery in patients with myocardial infarction with ST-segment elevation. However, the embolization of atherothrombotic debris induces microvascular obstruction and diminishes myocardial reperfusion.